Search results
Moderna’s long Covid plan
Politico· 4 days agoEven so: Rizkalla said Moderna...immune response to the virus. Rizkalla declined to offer any timeline for Moderna’s development efforts ...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 2 days agoSo, investors should expect solid clinical and regulatory progress moving forward for the biotech. ...
AstraZeneca aims increase its annual revenue by 75% in its post-COVID era
Quartz· 6 days agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Digital Journal· 5 days agoBy working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest ...
Ayahuasca, Abortion And Brain Worms At An RFK Jr. Rally In Colorado
HuffPost via Yahoo News· 3 days agoKennedy’s entourage included former Pussycat Dolls member Jessica Sutta, a self-described “vaccine...
Moderna director Afeyan sells over $2.3 million in company stock By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a portion of his holdings in the...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 4 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts
InvestorPlace· 4 days agoIndeed, the company has climbed 44% so far this year as one of the big winners of 2024’s bull market. Vaccine stocks have been on the climb this week amid reports of new human ...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 3 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Moderna Options Trading: A Deep Dive into Market Sentiment - Moderna (NASDAQ:MRNA)
Benzinga· 4 days agoThe firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020 ...